Drug Profile
Estriol/trimegestone vaginal ring - Evestra
Alternative Names: EVE 116Latest Information Update: 19 Mar 2021
Price :
$50
*
At a glance
- Originator Evestra
- Class Estrenes; Hormonal replacements; Norpregnadienes; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Pregnancy
Most Recent Events
- 19 Mar 2021 Phase-II development is ongoing for Pregnancy (Prevention, In volunteers) in Germany (Evestra pipeline, September 2020)
- 24 Feb 2020 Evestra completes phase II clinical trials in Pregnancy (Prevention, In volunteers) in Germany (Vaginal) (EudraCT2017-004664-36)
- 28 Jun 2018 Estriol/trimegestone vaginal ring - Evestra is available for licensing as of 28 Jun 2018. http://www.evestra.com/index.htm